## **Core Concept**
Medullary thyroid carcinoma (MTC) is a type of thyroid cancer that originates from the parafollicular cells, also known as C cells, which produce **calcitonin**. Screening for MTC often involves measuring the levels of a specific tumor marker.

## **Why the Correct Answer is Right**
The correct answer, **calcitonin**, is a hormone produced by the parafollicular C cells of the thyroid gland. Elevated levels of calcitonin are a sensitive and specific marker for medullary thyroid carcinoma. Measuring calcitonin levels is a widely accepted screening method for MTC, especially in individuals with a family history of the disease or in those with multiple endocrine neoplasia type 2 (MEN 2).

## **Why Each Wrong Option is Incorrect**
- **Option A:** While thyroid-stimulating hormone (TSH) is a useful marker for evaluating thyroid function and screening for thyroid disorders, it is not specific for medullary thyroid carcinoma.
- **Option B:** Free thyroxine (FT4) and free triiodothyronine (FT3) are also markers of thyroid function but are not specific for MTC.
- **Option D:** Carcinoembryonic antigen (CEA) can be elevated in various types of cancers, including MTC, but it is not as specific or sensitive as calcitonin for screening MTC.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **calcitonin levels should be measured in patients with a family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2)**. Additionally, it's worth noting that pentagastrin-stimulated calcitonin testing can be used to detect MTC in patients with inconclusive basal calcitonin levels.

## **Correct Answer:** . **Calcitonin**